The invention relates to 1,2,3,4-tetrahydroquinoxaline novel derivatives of common formula (1), containing a phenyl group as a substituent. The phenyl group includes sulfonic acid ester. The invention also relates to their application as glucocorticoid receptor agonist, particularly for bone-joint and ophthalmic inflammatory diseases treatment.